Toshitsugu Takekoshi
Hiroshima University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Toshitsugu Takekoshi.
Cancer Letters | 2000
Yasusei Kudo; Takashi Takata; Ikuko Ogawa; Ming Zhao; Sunao Sato; Toshitsugu Takekoshi; Mutsumi Miyauchi
Down-regulation of p27Kip1 has been reported to correlate with poor survival of various carcinoma patients including oral squamous cell carcinomas (OSCCs). It is still unclear, however, at what stage of oral carcinogenesis the down-regulation of this protein occurs. In this study, therefore, we evaluated immunoexpression of p27Kip1 protein in 17 cases of oral epithelial dysplasia and succeeding invasive OSCC in the same patient. We reported here that 88% cases showed high p27Kip1 expression in dysplastic lesions, whereas 82% cases of succeeding invasive OSCC exhibited reduced expression. The reduction of p27Kip1 expression was also observed in 16 of 19 (84%) early invasive lesions and well correlated with Ki-67 expression which is good indicator of cell proliferation. We also investigated immunoexpression of p53 protein of which abnormality has been known to occur during the early stage of OSCC development. Overexpression of p53 protein was demonstrated in 29% of dysplastic lesions, 42% of early invasive and 71% of invasive OSCCs. These findings suggest that abnormalities of both p53 and p27Kip1 are involved in the carcinogenesis of OSCC, but they seem to play their role at different stages of oral cancer development, respectively. Reduced expression of p27Kip1 may concern the cancer invasion directly or indirectly as well as abnormal proliferation.
Oral Oncology | 2000
Sunao Sato; Mutsumi Miyauchi; Toshitsugu Takekoshi; Ming Zhao; Yasusei Kudo; Ikuko Ogawa; Shoji Kitagawa; Minoru Fujita; Takashi Takata
Expression of CD44v9 was immunohistochemically studied in 120 biopsy specimens from primary squamous cell carcinoma (SCC) of the tongue and correlated with clinicopathological findings of the SCCs. The tumors were classified into three groups according to immunostaining pattern of CD44v9; 53 cases with distinct positivity in all cancer cells except for those in the central part of nests (Group 1, non-reduced group), 42 cases with reduced expression in peripheral cells of nests (Group 2, reduced group), and 25 cases with complete disappearance of the expression in one or more nests (Group 3, negative group). Nineteen of 25 (76%) tumors in Group 3 and 14 of 42 (33%) in Group 2 exhibited lymph node metastasis, compared with only 8 of 53 (15%) in Group 1. The average survival time in Groups 1, 2 and 3 was 4496+/-204, 3866+/-379 and 2719+/-359 days, respectively and became shorter with the reduction of CD44v9 expression. These results suggest that the down-regulation of CD44v9 in SCC of the tongue may relate to the detachment of tumor cells from primary lesions, establishment of lymph node metastasis and consequently the death of patients.
Pathology Research and Practice | 1999
Takashi Takata; Mutsumi Miyauchi; Hiroshi Ito; Ikuko Ogawa; Yasusei Kudo; Ming Zhao; Sunao Sato; Toshitsugu Takekoshi; Keiji Tanimoto
Desmoplastic ameloblastoma (DA) is an unusual subtype of ameloblastoma characterized by pronounced desmoplastic stroma. There is, however, still argument whether DA is a distinct clinicopathologic entity. To enhance knowledge of DA, 7 cases of DA (7.9%) were retrieved from 89 ameloblastomas field in the Department of Oral Pathology, Hiroshima University School of Dentistry and analyzed clinicopathologically and histopathologically. The mean age of the patients with DA and non-DA at the time of the diagnosis was 40.6 +/- 5.9 years and 33.1 +/- 2.0 years, respectively. The male-to-female ratio was 2.5:1 in DA and 1.8:1 in non-DA. Four (57%) DAs were located in the maxilla where only 6% of the non-DA occurred. Interestingly, all DAs arose in the anterior/premolar area of the jaws and 6 cases were located mainly within the alveolus. None of the DA showed typical radiographic features of ameloblastoma. In 5 DAs, scattered radiopacities were observed in the radiolucent lesion and gave preoperative diagnoses of non-ameloblastomatous lesions or even osteosarcoma. All DAs showed pronounced desmoplastic stroma where there were compressed tumor islands usually lacking a peripheral layer of ameloblastic cells and a central zone of stellate reticulum. There was cystic change within the epithelial nests in 3 DAs and true glandular structures with mucus cells in a case of DA. Tumor islands often infiltrated into marrow spaces of surrounding bone. There was no capsule formation. Recurrence rate was 14% in DA and 20% in non-DA. The present study based on data of DA in the Japanese population supports that DA must be considered as a distinct clinicopathologic entity.
Pathology International | 1999
Takashi Takata; Mutsumi Miyauchi; Ikuko Ogawa; Ming Zhao; Yasusei Kudo; Sunao Sato; Toshitsugu Takekoshi; Keiji Tanimoto
So‐called ‘hybrid’ lesion of ameloblastoma, which is composed of desmoplastic ameloblastoma and conventional follicular/plexiform ameloblastoma, is an unusual variant of ameloblastoma and only eight cases of ‘hybrid’ lesion have been published in the English literature. To enhance knowledge of this interesting tumor, we add a case of ‘hybrid’ lesion that occurred in the right mandible of a 48‐year‐old Japanese male. Radiographic examination disclosed a honeycomb appearance at the anterior alveolar region, combined with a unicystic radiolucency in the molar region of the mandibular body. Histologically, the former showed microscopic features of desmoplastic ameloblastoma and the latter those of follicular ameloblastoma with focal granular cell transformation. The lesion was enucleated with curettage of surrounding bone and the lesional cavity was marsupialized. Although tumor tissues reappeared at 3, 5, 7 and 14 months after the surgery, the patient has remained disease free for 11 years after the last vaporization by CO2 laser of the recurred tumor. Many more cases of ‘hybrid’ lesion are needed to clarify the clinicopathological, histopathological and biological characteristics of this interesting variant of ameloblastoma.
Archives of Oral Biology | 1998
Hiroshi Ito; Toshitsugu Takekoshi; Mutsumi Miyauchi; Ikuko Ogawa; Takashi Takata; Kazuhisa Takemoto
Detailed three-dimensional morphological information of the cell without distortion due to thin sectioning can be obtained from thick sections using a confocal laser scanning microscope. Here that microscope was used to evaluate human gingival Langerhans cells stained with anti-CD1a antibody. Optical sectioning and reconstruction by laser scanning microscopy revealed not only three-dimensional aspects of Langerhans cells but also spatial information on the distribution of their dendritic processes towards the gingival surface. The orientated configuration of those processes may reflect the reaction of the gingival Langerhans cell to the surrounding moist environment containing antigenic stimuli originating in saliva.
Clinical Cancer Research | 2000
Yasusei Kudo; Takashi Takata; Ikuko Ogawa; Toshihiko Kaneda; Sunao Sato; Toshitsugu Takekoshi; Ming Zhao; Mutsumi Miyauchi
Cancer | 1998
Yasusei Kudo; Takashi Takata; Wataru Yasui; Ikuko Ogawa; Mutsumi Miyauchi; Toshitsugu Takekoshi; Eiichi Tahara
Bone | 2006
Toshihiko Kaneda; Mutsumi Miyauchi; Toshitsugu Takekoshi; Shoji Kitagawa; Masae Kitagawa; Hideki Shiba; Hidemi Kurihara; Takashi Takata
Journal of Oral Pathology & Medicine | 2007
Ming Zhao; Takashi Takata; Ikuko Ogawa; Toshitsugu Takekoshi
Journal of Periodontal Research | 1998
Mutsumi Miyauchi; Takashi Takata; Hiroshi Ito; Ikuko Ogawa; Yasusel Kudo; Toshitsugu Takekoshi